Showing 1 - 7 of 7
Persistent link: https://www.econbiz.de/10013060433
The zeitgeist of this century and the foreseeable future is not only to celebrate humanity's cultural heritage but to also preserve and maintain it for future generations, whilst ensuring its current accessibility to the public. This task is vested in libraries, museums, archives and other...
Persistent link: https://www.econbiz.de/10012925050
There has been, in the last two decades, a growing belief within the intellectual property fraternity as to the desirability for and the relevance of a further tier of patent-like protection within the general intellectual property framework. Such laws, usually referred to as utility model laws,...
Persistent link: https://www.econbiz.de/10012852696
Exclusionary subject matter are often underpinned by public interest considerations. In the case of shapes of products, the Court of Justice of the European Union has aligned the interpretation of the relevant exclusionary provisions within design and trade mark laws . More recently, European...
Persistent link: https://www.econbiz.de/10013252387
The original TRIPS waiver proposal made by India and South Africa in October 2020 was based on the need for affordable access to medical products for the prevention, containment of treatment of COVID-19 during the pandemic. That proposal sought to bring into force a waiver of WTO States’ TRIPS...
Persistent link: https://www.econbiz.de/10014082995
The temporary TRIPS waiver - as proposed by India and South Africa and supported by more than 100 countries - is a necessary and proportionate legal measure towards the clearing of existing intellectual property barriers to scaling up of production of COVID-19 health technologies in a direct,...
Persistent link: https://www.econbiz.de/10013219622
Prompt and affordable access to essential medicines is a component of almost all domestic and global public health models. As is now well known, the availability and costs of both brand and generic drugs is a function of traditional patent law incentives. Less known, however, is that generic...
Persistent link: https://www.econbiz.de/10014189151